Induced Pluripotent Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global induced pluripotent stem cells market is experiencing a dynamic transformation with a select group of companies dedicating themselves to providing life science reagents and products. While numerous players, both large-scale and regional, participate in the induced pluripotent stem cells market, a few stand out with their exclusive focus on delivering high-quality products. This specialization not only ensures superior product quality but also fosters customer loyalty and establishes a robust distribution network that extends worldwide.

Rising Investments in Research and Development

The ever-increasing investments by companies in life sciences research and development present promising growth prospects. Companies that supply tools and products to cater to the research needs of healthcare providers and research institutes can anticipate stable returns. Over the past years, substantial investments in basic-level research, primarily by research organizations and academic institutes, have led to a deeper understanding of the fundamental pathways associated with induced pluripotent stem cells and their implications in disease development. This newfound knowledge raises more questions about biology, disease causation, and potential diagnostics and treatments.

Induced pluripotent stem cells exhibit a gene expression signature similar to that of embryonic stem cells, showcasing both pluripotency and self-renewal capabilities. As researchers delve deeper into these pathways, the complexity of products requested has grown, reflecting an improved understanding of fundamental pathways and the discovery of new ones.

Adapting to the Changing Landscape

Manufacturers of research products must stay aligned with the latest developments to meet the evolving requirements of the life sciences industry. The ability to provide cutting-edge solutions is crucial as researchers continually push the boundaries of knowledge.

North America Leading the Way

North America is poised to take the lead in the global induced pluripotent stem cells market, driven by a surge in research and clinical trials. Recent advancements in induced pluripotent stem cells technology, particularly in North American research institutes, have ensured a steady supply of functional cells for pre-clinical drug screening. Induced pluripotent stem cells offer a unique platform for disease modeling on a patient-by-patient basis, allowing for a deep understanding of disease progression and individualized pharmacological drug screening.

The region's focus on micromedicine enables the analysis of drug effectiveness at the individual patient level, while high-throughput drug toxicity screenings using human iPSC-derived cardiomyocytes are becoming commonplace. Ongoing research activities in North America are expected to attract future investments in the induced pluripotent stem cells market.

Europe's Growing Role

Europe is gearing up for significant participation in the induced pluripotent stem cells market, buoyed by the growth of the contract research industry. The region has become a hub for biopharmaceutical companies, both small and large, and relies on contract research organizations and clinical services for research and development operations. Outsourcing of iPSC trials has streamlined drug approval processes, ensuring Europe's continued prominence in the global induced pluripotent stem cells market.

Induced Pluripotent Stem Cells Market Segmentation:

Cell Type

Hepatocytes
Fibroblasts
Keratinocytes
Neurons
Others

Application

Drug Development
Regenerative Medicine
Toxicity Testing

End User

Academic and Research Institutes
Biotechnology Companies

Region

North America
Latin America
Europe
Asia Pacific excluding China (APEC)
China
Middle East and Africa (MEA)

1. Executive Summary

1.1. Global Induced Pluripotent Stem Cells Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

3.1. Global Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Instruments/Devices
  - 3.1.1.2. Automated Platforms
  - 3.1.1.3. Consumables & Kits
    - 3.1.1.3.1. Media
    - 3.1.1.3.2. Kits
    - 3.1.1.3.3. Others
  - 3.1.1.4. Services
3.2. Global Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Manual
  - 3.2.1.2. Automated
3.3. Global Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Reprogramming
  - 3.3.1.2. Cell Culture
  - 3.3.1.3. Cell Characterization/Analysis
  - 3.3.1.4. Engineering
  - 3.3.1.5. Others
3.4. Global Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Drug Development and Discovery
  - 3.4.1.2. Regenerative Medicine
  - 3.4.1.3. Toxicology Studies
  - 3.4.1.4. Others
3.5. Global Induced Pluripotent Stem Cells Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

4.1. North America Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Instruments/Devices
  - 4.1.1.2. Automated Platforms
  - 4.1.1.3. Consumables & Kits
    - 4.1.1.3.1. Media
    - 4.1.1.3.2. Kits
    - 4.1.1.3.3. Others
  - 4.1.1.4. Services
4.2. North America Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Manual
  - 4.2.1.2. Automated
4.3. North America Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Reprogramming
  - 4.3.1.2. Cell Culture
  - 4.3.1.3. Cell Characterization/Analysis
  - 4.3.1.4. Engineering
  - 4.3.1.5. Others
4.4. North America Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Drug Development and Discovery
  - 4.4.1.2. Regenerative Medicine
  - 4.4.1.3. Toxicology Studies
  - 4.4.1.4. Others
4.5. North America Induced Pluripotent Stem Cells Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

5.1. Europe Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Instruments/Devices
  - 5.1.1.2. Automated Platforms
  - 5.1.1.3. Consumables & Kits
    - 5.1.1.3.1. Media
    - 5.1.1.3.2. Kits
    - 5.1.1.3.3. Others
  - 5.1.1.4. Services
5.2. Europe Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Manual
  - 5.2.1.2. Automated
5.3. Europe Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Reprogramming
  - 5.3.1.2. Cell Culture
  - 5.3.1.3. Cell Characterization/Analysis
  - 5.3.1.4. Engineering
  - 5.3.1.5. Others
5.4. Europe Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Drug Development and Discovery
  - 5.4.1.2. Regenerative Medicine
  - 5.4.1.3. Toxicology Studies
  - 5.4.1.4. Others
5.5. Europe Induced Pluripotent Stem Cells Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

6.1. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Instruments/Devices
  - 6.1.1.2. Automated Platforms
  - 6.1.1.3. Consumables & Kits
    - 6.1.1.3.1. Media
    - 6.1.1.3.2. Kits
    - 6.1.1.3.3. Others
  - 6.1.1.4. Services
6.2. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Manual
  - 6.2.1.2. Automated
6.3. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Reprogramming
  - 6.3.1.2. Cell Culture
  - 6.3.1.3. Cell Characterization/Analysis
  - 6.3.1.4. Engineering
  - 6.3.1.5. Others
6.4. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Drug Development and Discovery
  - 6.4.1.2. Regenerative Medicine
  - 6.4.1.3. Toxicology Studies
  - 6.4.1.4. Others
6.5. Asia Pacific Induced Pluripotent Stem Cells Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

7.1. Latin America Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Instruments/Devices
  - 7.1.1.2. Automated Platforms
  - 7.1.1.3. Consumables & Kits
    - 7.1.1.3.1. Media
    - 7.1.1.3.2. Kits
    - 7.1.1.3.3. Others
  - 7.1.1.4. Services
7.2. Latin America Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
7.3. Latin America Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Reprogramming
  - 7.3.1.2. Cell Culture
  - 7.3.1.3. Cell Characterization/Analysis
  - 7.3.1.4. Engineering
  - 7.3.1.5. Others
7.4. Latin America Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Drug Development and Discovery
  - 7.4.1.2. Regenerative Medicine
  - 7.4.1.3. Toxicology Studies
  - 7.4.1.4. Others
7.5. Latin America Induced Pluripotent Stem Cells Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, 2018 - 2031

8.1. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Instruments/Devices
  - 8.1.1.2. Automated Platforms
  - 8.1.1.3. Consumables & Kits
    - 8.1.1.3.1. Media
    - 8.1.1.3.2. Kits
    - 8.1.1.3.3. Others
  - 8.1.1.4. Services
8.2. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, by Process, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Manual
  - 8.2.1.2. Automated
8.3. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, by Workflow, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Reprogramming
  - 8.3.1.2. Cell Culture
  - 8.3.1.3. Cell Characterization/Analysis
  - 8.3.1.4. Engineering
  - 8.3.1.5. Others
8.4. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Drug Development and Discovery
  - 8.4.1.2. Regenerative Medicine
  - 8.4.1.3. Toxicology Studies
  - 8.4.1.4. Others
8.5. Middle East & Africa Induced Pluripotent Stem Cells Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Induced Pluripotent Stem Cells Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Induced Pluripotent Stem Cells Market by Process, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Induced Pluripotent Stem Cells Market by Workflow, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Induced Pluripotent Stem Cells Market by Application, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. by Workflow vs by Process Heatmap
9.2. Manufacturer vs by Process Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. LONZA
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Axol Biosciences Ltd
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Evotec
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Hitachi Ltd
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Reprocell Inc
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Thermo Fisher Scientific, Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Merck Kgaa (Milliporesigma)
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. StemCellFactory I I I
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Applied Stemcell Inc
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations